Ethanolic Extract of Atractylodis Rhizoma Ameliorates DSS-Induced Ulcerative Colitis via Improving Intestinal Barrier Function Through the Rho-Associated Kinase/Myosin Light Chain Pathway
Journal of Medicinal Food · 2025
DOI: 10.1089/jmf.2024.k.0281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Food, 2025. Verfasst von Zengxiang Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, People's Republic of China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, rho-Associated Kinases, Myosin Light Chains, Atractylodes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
The utilization of traditional Chinese medicine (TCM) for disease treatment dates back thousands of years. Atractylodis rhizoma (AR) is recognized as a premier TCM and has effective therapeutic properties for gastrointestinal disorders. Nonetheless, the underlying mechanisms by which the ethanolic extract of Atractylodis rhizoma (EEAR) addresses ulcerative colitis (UC) remain ambiguous. This study aimed to clarify the potential molecular mechanisms by which EEAR ameliorated dextran sodium sulfate (DSS)-induced UC in mouse models and Caco-2 cells. EEAR exhibited significant therapeutic effects in UC mice, including decreasing symptoms and reducing inflammation. It also upregulated the expressions of tight junction (TJ) proteins, which enhanced UC intestinal mucosal barrier protection. In addition, EEAR inhibited the expressions of matrix metalloprotein (MMP)-2/9 proteins and inactivated the RhoA/ROCK (Rho-associated kinase)/MLC (myosin light chain) pathway in UC mice. Consistent with the results of in vivo experiments, EEAR significantly increased cell viability and improved the barrier disruption in DSS-induced Caco-2 cells. EEAR increased the expressions of TJ proteins, regulated F-actin cytoskeletal remodeling, and inhibited the expressions of MMP-2/9 proteins and the RhoA/ROCK/MLC pathway. EEAR significantly decreased intestinal pathological injury. Its potential mechanism was related to its inhibition of the RhoA/ROCK/MLC pathway, decreased activation of MMP-2/9, and increased expressions of TJ proteins, thereby regulating cytoskeleton remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, People's Republic of China.
- Hubei Shizhen Laboratory, Wuhan, People's Republic of China.
- Key Laboratory of Traditional Chinese Medicine Resource and Compound Prescription, Ministry of Education, Hubei University of Chinese Medicine, Wuhan, People's Republic of China.
ORCID-Profile: Zengxiang Gao
Zitieren
APA
Gao, Z., Huang, P., Yu, X., Dong, R., Lin, Y., Tu, J., Chen, L., Cao, Y., Liu, Y., Yang, D., & Cao, G. (2025). Ethanolic Extract of Atractylodis Rhizoma Ameliorates DSS-Induced Ulcerative Colitis via Improving Intestinal Barrier Function Through the Rho-Associated Kinase/Myosin Light Chain Pathway. Journal of Medicinal Food. https://doi.org/10.1089/jmf.2024.k.0281
Vancouver
Gao Z, Huang P, Yu X, Dong R, Lin Y, Tu J, et al. Ethanolic Extract of Atractylodis Rhizoma Ameliorates DSS-Induced Ulcerative Colitis via Improving Intestinal Barrier Function Through the Rho-Associated Kinase/Myosin Light Chain Pathway. Journal of Medicinal Food. 2025. doi:10.1089/jmf.2024.k.0281
BibTeX
@article{Gao2025,
author = {Gao, Zengxiang and Huang, Peng and Yu, Xuecheng and Dong, Ruotong and Lin, Yunya and Tu, Jiyuan and Chen, Linlin and Cao, Yan and Liu, Yanju and Yang, Desen and Cao, Guosheng},
title = {Ethanolic Extract of Atractylodis Rhizoma Ameliorates DSS-Induced Ulcerative Colitis via Improving Intestinal Barrier Function Through the Rho-Associated Kinase/Myosin Light Chain Pathway},
journal = {Journal of Medicinal Food},
year = {2025},
doi = {10.1089/jmf.2024.k.0281}
}
EUVIMED